BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Hythiam, Inc. 

11111 Santa Monica Boulevard, Suite 550

Los Angeles  California  90025  U.S.A.
Phone: 310-268-0011 Fax: 310-268-0012


SEARCH JOBS




Industry
Biotechnology

Segment
Research





 Company News
Hythiam, Inc. Announces Peer-Reviewed Publication of Randomized, Double-Blind, Placebo-Controlled Study 2/10/2010 9:52:56 AM
Hythiam, Inc. CEO Interviewed on CorporateProfile.com 1/29/2010 12:03:32 PM
Hythiam, Inc. Announces Publication on Predictive Modeling for Substance Dependent Populations in Perspectives in Health Information Management 1/13/2010 9:34:27 AM
Hythiam, Inc. Announces First Peer-Reviewed Publication of Statistically Significant Results from Randomized, Double-Blind, Placebo-Controlled Study 9/28/2009 10:09:10 AM
Hythiam, Inc. Announces Fourth Quarter and 2008 Year-End Results 4/1/2009 11:19:43 AM
Hythiam, Inc. Announces Results of Two Double-Blind, Placebo-Controlled Studies on Impact of PROMETA(R) Treatment Program for Alcohol Dependence 3/26/2009 9:42:44 AM
Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam, Inc.’s PROMETA(R) Treatment Program 11/18/2008 9:52:00 AM
Double-Blind, Placebo-Controlled Alcohol Study of Hythiam, Inc.'s Prometa Treatment Program Demonstrated Statistically Significant Improvement in Patients with Symptoms of Alcohol Withdrawal 7/8/2008 9:15:08 AM
Intent-to-Treat Analysis of Double-Blind Methamphetamine Study Confirms Hythiam, Inc.'s PROMETA Treatment Program Showed Statistically Significant Reduction in Cravings Compared to Placebo 6/19/2008 9:04:08 AM
Russian Patent Office Provides Notification of Intention to Grant Hythiam, Inc. Patent for Treatment of Cocaine Dependence 11/5/2007 11:14:27 AM
123